欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2519/002
药品名称Propofol Pfizer 20 mg/ml
活性成分
    • propofol 20.0 mg/ml
剂型Emulsion for injection or infusion
上市许可持有人Pfizer Pharma GmbH Linkstrasse 10 10785 Berlin Germany
参考成员国 - 产品名称Germany (DE)
Propofol Pfizer 20 mg/ml Emulsion zur Injektion oder Infusion
互认成员国 - 产品名称
    • Portugal (PT)
    • Belgium (BE)
    • Latvia (LV)
    • Luxembourg (LU)
    • Austria (AT)
      Propofol Pfizer 20 mg/ml Emulsion zur Injektion/Infusion
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Cyprus (CY)
      PROPOFOL PFIZER 20mg/ml EMULSION FOR INJECTION OR INFUSION
    • Romania (RO)
      Propofol Pfizer 20 mg/ml emulsie injectabilă/perfuzabilă
    • Malta (MT)
      Propofol Pfizer 20mg/ml Emulsion for Injection/Infusion
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
许可日期2011/04/28
最近更新日期2015/09/29
药物ATC编码
    • N01AX10 propofol
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase